Scribe Therapeutics Pioneers Epigenetic Silencing for Cardiovascular Disease, Navigating a Cautious Gene Editing IPO Market
In a striking juxtaposition of industrial heritage and futuristic biotechnology, Scribe Therapeutics, a burgeoning gene...
Knowledge and News for the Global Fight Against Cancer.
In a striking juxtaposition of industrial heritage and futuristic biotechnology, Scribe Therapeutics, a burgeoning gene...
CureSearch for Children’s Cancer, a leading global nonprofit focused on accelerating the development of new...
Jazz Pharmaceuticals has announced its acquisition of Actio Biosciences in an upfront deal valued at...
Neuroblastoma represents the most frequently diagnosed extracranial solid tumor in the pediatric population, originating within...
San Diego, CA — August 10, 2026 — Sionna Therapeutics experienced a dramatic collapse in...
The landscape of pediatric oncology research has reached a significant milestone with the announcement that...
The pharmaceutical industry, a crucible of innovation and a beacon of hope for countless patients,...
Brain tumors represent the most lethal form of pediatric cancer, currently standing as the leading...
The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to OJEMDA (tovorafenib)...
The landscape of pediatric oncology often involves stories of immense resilience, and the case of...